166 related articles for article (PubMed ID: 28604229)
1. Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer.
Ota K; Adar T; Dover L; Khachemoune A
J Dermatolog Treat; 2018 Mar; 29(2):170-175. PubMed ID: 28604229
[TBL] [Abstract][Full Text] [Related]
2. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer.
Bhatnagar A; Loper A
Radiat Oncol; 2010 Sep; 5():87. PubMed ID: 20875139
[TBL] [Abstract][Full Text] [Related]
3. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
4. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
[TBL] [Abstract][Full Text] [Related]
5. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
Bhatnagar A
Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
8. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract][Full Text] [Related]
9. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
[TBL] [Abstract][Full Text] [Related]
10. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report.
Ouhib Z; Kasper M; Perez Calatayud J; Rodriguez S; Bhatnagar A; Pai S; Strasswimmer J
Brachytherapy; 2015; 14(6):840-58. PubMed ID: 26319367
[TBL] [Abstract][Full Text] [Related]
11. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
13. High dose rate brachytherapy in nonmelanoma skin cancer-Systematic review.
Krzysztofiak T; Kamińska-Winciorek G; Pilśniak A; Wojcieszek P
Dermatol Ther; 2022 Sep; 35(9):e15675. PubMed ID: 35770511
[TBL] [Abstract][Full Text] [Related]
14. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
15. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
[TBL] [Abstract][Full Text] [Related]
16. Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study.
Patel R; Strimling R; Doggett S; Willoughby M; Miller K; Dardick L; Mafong E
J Contemp Brachytherapy; 2017 Aug; 9(4):338-344. PubMed ID: 28951753
[TBL] [Abstract][Full Text] [Related]
17. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.
Rodríguez S; Arenas M; Gutierrez C; Richart J; Perez-Calatayud J; Celada F; Santos M; Rovirosa A
Clin Transl Oncol; 2018 Apr; 20(4):431-442. PubMed ID: 28808925
[TBL] [Abstract][Full Text] [Related]
18. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds.
Gonzalez-Perez V; Rembielak A; Guinot JL; Jaberi R; Lancellotta V; Walter R; Zuchora A; Budrukkar A; Kovács G; Jürgenliemk-Schulz I; Siebert FA; Tagliaferri L
Radiother Oncol; 2022 Oct; 175():122-132. PubMed ID: 36030932
[TBL] [Abstract][Full Text] [Related]
19. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer.
Lancellotta V; Kovács G; Tagliaferri L; Perrucci E; Rembielak A; Stingeni L; Tramontana M; Hansel K; Colloca G; Saldi S; Valentini V; Aristei C
J Geriatr Oncol; 2019 May; 10(3):514-517. PubMed ID: 30314955
[TBL] [Abstract][Full Text] [Related]
20. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
